OPEN END TURBO LONG - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME3HKW1

Real-time Bid/Ask 10:19:26 2024-06-18 am EDT
4.21 EUR / 4.24 EUR +3.81% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO.
Current month+3.56%
1 month-8.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-18 4.06 -0.25%
24-06-17 4.07 -3.55%
24-06-14 4.22 +4.20%
24-06-13 4.05 -5.59%
24-06-12 4.29 -1.38%

Delayed Quote Börse Stuttgart

Last update June 18, 2024 at 06:50 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME3HKW
ISINDE000ME3HKW1
Date issued 2023-11-13
Strike 189 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.99
Lowest since issue 3.33
Spread 0.03
Spread %0.71%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232.8 USD
Average target price
279.2 USD
Spread / Average Target
+19.95%
Consensus